Literature DB >> 18662734

Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.

Hoyin Mok1, Sujin Lee, David W Wright, James E Crowe.   

Abstract

Cytotoxic T lymphocytes (CTLs) are critical for the control of respiratory syncytial virus infection (RSV) in humans and mice. Recently, we identified a new H-2K(d)-restricted subdominant epitope in the respiratory syncytial virus M2 protein. In this study, we investigated if modification of anchor residues at positions 2 and 9 in the dominant M2(82-90) epitope in the M2 protein would alter the CTL epitope dominance hierarchy following immunization with plasmid DNA encoding M2 proteins. We showed that immunogenicity of the subdominant epitope M2(127-135) was enhanced when the anchor residues of the dominant epitope were mutated, suggesting that the immunodominant epitope induces a suppression of response to the subdominant epitope.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662734      PMCID: PMC2561208          DOI: 10.1016/j.vaccine.2008.07.012

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  36 in total

1.  Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system.

Authors:  C C Bergmann; J D Altman; D Hinton; S A Stohlman
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

Review 2.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

Authors:  J W Yewdell; J R Bennink
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

3.  The isolation of respiratory syncytial virus from children with acute respiratory disease.

Authors:  A HOLZEL; L PARKER; W H PATTERSON; L L WHITE; K M THOMPSON; J O TOBIN
Journal:  Lancet       Date:  1963-02-09       Impact factor: 79.321

4.  Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes.

Authors:  Nicole Frahm; Photini Kiepiela; Sharon Adams; Caitlyn H Linde; Hannah S Hewitt; Kaori Sango; Margaret E Feeney; Marylyn M Addo; Mathias Lichterfeld; Matthew P Lahaie; Eunice Pae; Alysse G Wurcel; Timothy Roach; M Anne St John; Marcus Altfeld; Francesco M Marincola; Corey Moore; Simon Mallal; Mary Carrington; David Heckerman; Todd M Allen; James I Mullins; Bette T Korber; Philip J R Goulder; Bruce D Walker; Christian Brander
Journal:  Nat Immunol       Date:  2005-12-20       Impact factor: 25.606

5.  Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization.

Authors:  T M Fu; A Friedman; J B Ulmer; M A Liu; J J Donnelly
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Respiratory syncytial virus infection in elderly and high-risk adults.

Authors:  Ann R Falsey; Patricia A Hennessey; Maria A Formica; Christopher Cox; Edward E Walsh
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

7.  Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.

Authors:  John A Rutigliano; Michael T Rock; Amanda K Johnson; James E Crowe; Barney S Graham
Journal:  Virology       Date:  2005-07-05       Impact factor: 3.616

Review 8.  Pathogenesis of respiratory syncytial virus vaccine-augmented pathology.

Authors:  B S Graham
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

9.  In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection.

Authors:  K Murali-Krishna; J D Altman; M Suresh; D Sourdive; A Zajac; R Ahmed
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

10.  Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children.

Authors:  R CHANOCK; L FINBERG
Journal:  Am J Hyg       Date:  1957-11
View more
  9 in total

1.  Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope.

Authors:  Tracy J Ruckwardt; Cindy Luongo; Allison M W Malloy; Jie Liu; Man Chen; Peter L Collins; Barney S Graham
Journal:  J Immunol       Date:  2010-09-10       Impact factor: 5.422

2.  Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice.

Authors:  Sujin Lee; Kate L Stokes; Michael G Currier; Kaori Sakamoto; Nicholas W Lukacs; Esteban Celis; Martin L Moore
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

Review 3.  DNA vaccines: developing new strategies against cancer.

Authors:  Daniela Fioretti; Sandra Iurescia; Vito Michele Fazio; Monica Rinaldi
Journal:  J Biomed Biotechnol       Date:  2010-03-28

4.  Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239.

Authors:  Mauricio A Martins; Nancy A Wilson; Shari M Piaskowski; Kim L Weisgrau; Jessica R Furlott; Myrna C Bonaldo; Marlon G Veloso de Santana; Richard A Rudersdorf; Eva G Rakasz; Karen D Keating; Maria J Chiuchiolo; Michael Piatak; David B Allison; Christopher L Parks; Ricardo Galler; Jeffrey D Lifson; David I Watkins
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

5.  Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes.

Authors:  Shayesteh R Ferdosi; Radwa Ewaisha; Farzaneh Moghadam; Sri Krishna; Jin G Park; Mo R Ebrahimkhani; Samira Kiani; Karen S Anderson
Journal:  Nat Commun       Date:  2019-04-23       Impact factor: 14.919

6.  Protective efficacy and immunogenicity of a combinatory DNA vaccine against Influenza A Virus and the Respiratory Syncytial Virus.

Authors:  Viktoria Stab; Sandra Nitsche; Thomas Niezold; Michael Storcksdieck Genannt Bonsmann; Andrea Wiechers; Bettina Tippler; Drew Hannaman; Christina Ehrhardt; Klaus Uberla; Thomas Grunwald; Matthias Tenbusch
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

Review 7.  Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases.

Authors:  Frances E Terry; Leonard Moise; Rebecca F Martin; Melissa Torres; Nils Pilotte; Steven A Williams; Anne S De Groot
Journal:  Expert Rev Vaccines       Date:  2014-09-05       Impact factor: 5.217

8.  Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2.

Authors:  Peiyang Ding; Teng Zhang; Yafei Li; Man Teng; Yaning Sun; Xiao Liu; Shujun Chai; Enmin Zhou; Qianyue Jin; Gaiping Zhang
Journal:  Int J Nanomedicine       Date:  2017-07-24

Review 9.  Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections.

Authors:  Catalina A Andrade; Gaspar A Pacheco; Nicolas M S Gálvez; Jorge A Soto; Susan M Bueno; Alexis M Kalergis
Journal:  Viruses       Date:  2020-06-12       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.